Ajai K. Chaudhary, Ph.D., Director, Merk Research Laboratories09.22.15
Current Challenges:
• Upcoming onslaught of expiring patents
• Increasing demands from payers and third party providers to demonstrate differentiation (therapeutic, cost etc.)
• More stringent regulatory requirement
Given the economic challenges and rapidly changing regulatory expectations the old model of drug discovery and development is no longer viable.
• Upcoming onslaught of expiring patents
• Increasing demands from payers and third party providers to demonstrate differentiation (therapeutic, cost etc.)
• More stringent regulatory requirement
Given the economic challenges and rapidly changing regulatory expectations the old model of drug discovery and development is no longer viable.